Products
Online Inquiry
CEP-33779
Inquiry
Cat. No.:
OB0125LY-077
Size:
1 mg; 2 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 500 mg
CAS No.:
1257704-57-6
Compound CID:
57336812
Specification
Description:
CEP-33779 is a selective inhibitor that effectively regulates the immune response by intervening in the JAK signaling pathway.
Formula Weight:
462.57
Stability:
3 years in powder form.
Applications:
CEP-33779 can be used in autoimmune disease and some cancer studies.
Storage:
Storage at -20°C.
Formula:
C24H26N6O2S
Appearance:
Solid
Purity:
99.4%
Identity:
Confirmed by NMR and HPLC.
Targets&IC50:
JAK2: 1.8±0.6 nM
Relative Density:
1.35 g/cm3
Library Information
Plate Number:
AOCL-18
Plate Location:
e7
Empty Location:
a1-h1; a12-h12
Formulation:
10mM DMSO
Container:
96-well plate
Pathways:
Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem cells
Targets:
JAK
Receptors:
JAK; JAK2
DMSO Max Solubility (mg/mL):
16.67 mg/mL
DMSO Max Solubility (mM):
36.03 mM
ALogP:
3.86
HBA_Count:
4
HBD_Count:
1
Rotatable Bond:
5